THE DUBERSTEIN GROUP INC. for AMGEN INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part D: -H.R.1625 (Royce) - Consolidated Appropriations Act, 2018 -H.R.1892 (Larson) - Bipartisan Budget Act of 2018 Biosimilars: -H.R.1625 (Royce) - Consolidated Appropriations Act, 2018 -H.R.1892 (Larson) - Bipartisan Budget Act of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Taxation/Internal Revenue Code TAX
Puerto Rico issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Budget/Appropriations BUD
Medicare Part D: -H.R.1625 (Royce) - Consolidated Appropriations Act, 2018 -H.R.1892 (Larson) - Bipartisan Budget Act of 2018 Biosimilars: -H.R.1625 (Royce) - Consolidated Appropriations Act, 2018 -H.R.1892 (Larson) - Bipartisan Budget Act of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.